Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 29-Dec-23 4:03 PM View:  | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Dec-23 | Option Exercise | 30,000 | $96.45 | $2,893,500.00 | 150% 20.03K to 50.03K | |
| 29-Dec-23 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Dec-23 | Planned Option Sale | 30,000 | $195.00 | $5,850,000.00 | (60%) 50.03K to 20.03K | |
| 04-Aug-23 4:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-23 | Option Sale | 6,448 | $185.38 | $1,195,310.00 | (24%) 26.48K to 20.03K | |
| 04-Aug-23 4:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Aug-23 | Option Exercise | 22,477 | -- | -- | 562% 4.0K to 26.48K | |
| 14-Jun-21 6:56 PM View: | Bristol-Myers Squibb Co. (BMY) | 13-Jun-21 | Option Exercise | 902 | -- | -- | 7% 13.6K to 14.5K | |
| 04-Jun-21 4:37 PM View: | Bristol-Myers Squibb Co. (BMY) | 03-Jun-21 | Option Exercise | 2,949 | -- | -- | 28% 10.65K to 13.6K | |
| 16-Jun-20 5:16 PM View: | Bristol-Myers Squibb Co. (BMY) | 14-Jun-20 | Option Exercise | 558 | -- | -- | 6% 10.09K to 10.65K | |
| 16-Jun-20 5:16 PM View: | Bristol-Myers Squibb Co. (BMY) | 13-Jun-20 | Option Exercise | 903 | -- | -- | 10% 9.19K to 10.09K | |
| 05-Jun-20 4:40 PM View: | Bristol-Myers Squibb Co. (BMY) | 03-Jun-20 | Option Exercise | 2,949 | -- | -- | 47% 6.24K to 9.19K | |
| 28-Feb-20 8:06 PM View: | AVI Biopharma, Inc. (SRPT) | 28-Feb-20 | Grant | 2,075 | -- | -- | 29% 7.05K to 9.13K | |
| 09-Jun-20 7:16 PM View: | Bristol-Myers Squibb Co. (BMY) | 04-Dec-19 | Market Purchase | 88 | $58.90 | $5,183.20 | < 1% 9.1K to 9.19K | 1% |
| 22-Nov-19 7:30 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 2,209 | -- | -- | (52%) 4.21K to 2.0K | |
| 22-Nov-19 7:30 AM View: | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 2,000 | -- | -- | (100%) 2.0K to 0 | |
| 09-Sep-19 2:18 PM View: | AVI Biopharma, Inc. (SRPT) | 09-Sep-19 | Market Purchase | 2,000 | $86.74 | $173,480.00 | 40% 5.05K to 7.05K | 102% |
| 17-Jun-19 4:00 PM View: | Celgene Corporation (CELG) | 15-Jun-19 | Option Exercise | 375 | -- | -- | 10% 3.83K to 4.21K | |
| 17-Jun-19 4:00 PM View: | Celgene Corporation (CELG) | 14-Jun-19 | Option Exercise | 300 | -- | -- | 8% 3.53K to 3.83K | |
| 17-Jun-19 4:00 PM View: | Celgene Corporation (CELG) | 13-Jun-19 | Option Exercise | 484 | -- | -- | 16% 3.05K to 3.53K | |
| 04-Mar-19 8:03 PM View: | AVI Biopharma, Inc. (SRPT) | 04-Mar-19 | Grant | 1,633 | -- | -- | 48% 3.42K to 5.05K | |
| 04-Mar-19 8:13 PM View: | Kaleido Biosciences, Inc. (KLDO) | 04-Mar-19 | Conversion | 417,673 | -- | -- | 41% 1.01M to 1.43M | |
| 04-Mar-19 8:13 PM View: | Kaleido Biosciences, Inc. (KLDO) | 04-Mar-19 | Conversion | 225,000 | -- | -- | 16% 1.43M to 1.65M | |
| 04-Mar-19 8:13 PM View: | Kaleido Biosciences, Inc. (KLDO) | 28-Feb-19 | Purchase | 71,520 | $13.98 | $999,492.00 | 8% 937.0K to 1.01M | |
| 14-Feb-20 10:00 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 27-Feb-19 | Gift | 150,000 | -- | -- | (70%) 215.35K to 65.35K | |
| 27-Jun-18 4:27 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 25-Jun-18 | Conversion | 21,847 | -- | -- | 11% 193.5K to 215.35K | |
| 15-Jun-18 4:17 PM View: | Celgene Corporation (CELG) | 15-Jun-18 | Option Exercise | 375 | -- | -- | 14% 2.67K to 3.05K | |
| 15-Jun-18 4:17 PM View: | Celgene Corporation (CELG) | 14-Jun-18 | Option Exercise | 300 | -- | -- | 13% 2.38K to 2.67K | |
| 07-Mar-18 6:02 PM View: | AVI Biopharma, Inc. (SRPT) | 05-Mar-18 | Grant | 3,418 | -- | -- | 100% 0 to 3.42K | |
| 16-Jun-17 4:06 PM View: | Celgene Corporation (CELG) | 15-Jun-17 | Option Exercise | 375 | -- | -- | 19% 2.0K to 2.38K | |
| 10-Mar-16 6:35 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Mar-16 | Market Purchase | 2,000 | $58.36 | $116,720.00 | 100% 2.0K to 4.0K | 43% |
| 04-Mar-16 4:33 PM View: | Celgene Corporation (CELG) | 03-Mar-16 | Market Purchase | 2,000 | $103.01 | $206,028.00 | 100% 0 to 2.0K | (12%) |
| 18-Aug-15 3:11 PM View: | Abrdn World Healthcare Fund (THW) | 17-Aug-15 | Market Purchase | 10,917 | $18.35 | $200,294.00 | 100% 0 to 10.92K | (28%) |
| 13-May-15 6:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-May-15 | Market Purchase | 2,000 | $112.16 | $224,320.00 | 100% 0 to 2.0K | (26%) |
| 24-Feb-15 9:17 PM View: | NPS Pharmaceuticals, Inc. (NPSPDE.OB) | 21-Feb-15 | Disposition (change in control) | 13,900 | $46.00 | $639,400.00 | (100%) 13.9K to 0 | |
| 21-Jan-15 5:06 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 21-Jan-15 | Disposition (other) | 176,226 | $102.00 | $17,975,100.00 | (96%) 183.64K to 7.42K | < 1% |
| 21-Jan-15 5:06 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 21-Jan-15 | Disposition (other) | 7,416 | $102.00 | $756,432.00 | (100%) 7.42K to 0 | < 1% |
| 29-Jul-14 4:28 PM View: | Abrdn Healthcare Opportunit... (THQ) | 28-Jul-14 | Purchase | 5,000 | $20.00 | $100,000.00 | 100% 0 to 5.0K | |
| 02-Jul-14 4:16 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 30-Jun-14 | Acquisition (other) | 367 | $57.87 | $21,237.60 | < 1% 183.28K to 183.64K | |
| 30-Jun-14 5:33 PM View: | H&Q Healthcare Investors (HQH) | 24-Jun-14 | Exercise (in-the money or at-the-money) | 1,102 | $25.04 | $27,590.80 | 145% 0.76K to 1.86K | |
| 30-Jun-14 5:34 PM View: | H&Q Life Sciences Investors (HQL) | 24-Jun-14 | Exercise (in-the money or at-the-money) | 1,459 | $19.75 | $28,815.20 | 157% 0.93K to 2.39K | (14%) |
| 15-May-14 2:42 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 15-May-14 | Market Option Sale | 3,036 | $67.50 | $204,930.00 | (2%) 186.31K to 183.28K | (50%) |
| 15-May-14 2:42 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 14-May-14 | Option Exercise | 6,250 | -- | -- | 3% 180.06K to 186.31K | |
| 14-May-14 4:10 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 14-May-14 | Market Option Sale | 3,840 | $69.00 | $264,960.00 | (2%) 183.9K to 180.06K | (47%) |
| 14-May-14 4:10 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 13-May-14 | Option Exercise | 8,000 | -- | -- | 5% 175.9K to 183.9K | |
| 02-Apr-14 3:39 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 31-Mar-14 | Acquisition (other) | 213 | $73.15 | $15,581.00 | < 1% 175.69K to 175.9K | 38% |
| 28-Feb-14 4:06 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 27-Feb-14 | Option Exercise | 100,000 | $10.84 | $1,084,000.00 | 57% 175.69K to 275.69K | |
| 28-Feb-14 4:06 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 27-Feb-14 | Market Option Sale | 100,000 | $81.25 | $8,125,130.00 | (36%) 275.69K to 175.69K | (25%) |
| 21-Feb-14 8:06 AM View: | Cubist Pharmaceuticals Inc. (CBST) | 20-Feb-14 | Market Option Sale | 3,112 | $75.60 | $235,268.00 | (2%) 178.8K to 175.69K | (34%) |
| 21-Feb-14 8:06 AM View: | Cubist Pharmaceuticals Inc. (CBST) | 19-Feb-14 | Option Exercise | 9,500 | -- | -- | 6% 169.3K to 178.8K | |
| 02-Jul-13 2:39 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 28-Jun-13 | Acquisition (other) | 579 | $36.69 | $21,241.20 | < 1% 168.72K to 169.3K | |
| 22-May-13 3:26 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 20-May-13 | Option Exercise | 60,000 | $12.61 | $756,600.00 | 36% 168.72K to 228.72K | |
| 22-May-13 3:26 PM View: | Cubist Pharmaceuticals Inc. (CBST) | 20-May-13 | Market Option Sale | 60,000 | $50.00 | $3,000,010.00 | (26%) 228.72K to 168.72K | (103%) |